ES8601706A1 - Una composicion farmaceutica - Google Patents
Una composicion farmaceuticaInfo
- Publication number
- ES8601706A1 ES8601706A1 ES532317A ES532317A ES8601706A1 ES 8601706 A1 ES8601706 A1 ES 8601706A1 ES 532317 A ES532317 A ES 532317A ES 532317 A ES532317 A ES 532317A ES 8601706 A1 ES8601706 A1 ES 8601706A1
- Authority
- ES
- Spain
- Prior art keywords
- delivery system
- drug delivery
- system utilizing
- drug
- application
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
Abstract
PROCEDIMIENTO PARA PREPARAR UNA COMPOSICION FARMAEUTICA ACUOSA. COMPRENDE: A) DEPOSITAR EN UN RECIPIENTE DE 10% A 50% EN PESO, CALCULADO SOBRE EL PESO TOTAL DE LA COMPOSICION, DE UN POLIMERO DE FORMULA (I); B) AGITAR EL RECIPIENTE DE LA ETAPA A); C) TAPAR EL RECIPIENTE E INTRODUCIRLO EN UN RECINTO FRIO A UNOS 0 A 10C PARA LOGRAR LA TOTAL DISOLUCION DEL POLIMERO; D) DISOLVER EN LA SOLUCION C) UNA CANTIDAD FARMACOLOGICAMENTE EFECTIVA DE UN FARMACO O AGENTE DE DIAGNOSTICO Y ADITIVOS; E) AJUSTAR EL PH DE LA SOLUCION ANTERIOR A ENTRE 2 Y 9 MEDIANTE UN ACIDO O BASE, PARA LOGRAR QUE LA COMPOSICION SEA LIQUIDA A TEMPERATURA AMBIENTE O POR DEBAJO DE ELLA; SIENDO W UN NUMERO ENTERO DE 2 A 6, QUE CONTIENE DE 40 A 80% DE POLI(OXIETILENO) Y DE 20 A 60% DE POLI(OXIPROPILENO) Y TIENE UN PESO MOLECULAR DE 7.000 A 50.000; X E Y SON NUMEROS ENTEROS.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/495,240 US4474752A (en) | 1983-05-16 | 1983-05-16 | Drug delivery system utilizing thermosetting gels |
US06/495,239 US4478822A (en) | 1983-05-16 | 1983-05-16 | Drug delivery system utilizing thermosetting gels |
US06/495,238 US4474751A (en) | 1983-05-16 | 1983-05-16 | Ophthalmic drug delivery system utilizing thermosetting gels |
US06/495,321 US4474753A (en) | 1983-05-16 | 1983-05-16 | Topical drug delivery system utilizing thermosetting gels |
Publications (2)
Publication Number | Publication Date |
---|---|
ES532317A0 ES532317A0 (es) | 1985-11-16 |
ES8601706A1 true ES8601706A1 (es) | 1985-11-16 |
Family
ID=27504371
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES532317A Expired ES8601706A1 (es) | 1983-05-16 | 1984-05-09 | Una composicion farmaceutica |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0126684B1 (es) |
CA (1) | CA1224148A (es) |
DE (1) | DE3484969D1 (es) |
DK (1) | DK164481C (es) |
ES (1) | ES8601706A1 (es) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT83095B (en) * | 1985-07-30 | 1987-12-23 | Int Minerals & Chem Corp | Method for the stabilization of growth promoting hormones using polyoxyethylene-polyoxypropylene copolymers |
DE3700911C2 (de) * | 1986-01-17 | 2001-05-17 | West Pharm Serv Drug Res Ltd | System zur Zuführung eines Arzneimittels oder eines Diagnostikums |
US4780320A (en) * | 1986-04-29 | 1988-10-25 | Pharmetrix Corp. | Controlled release drug delivery system for the periodontal pocket |
GB2203039B (en) * | 1987-03-02 | 1990-10-24 | American Cyanamid Co | Stable ophthalmic preparations containing acetazolamide |
US6436425B1 (en) | 1988-11-16 | 2002-08-20 | Mdv Technologies, Inc. | Method and non-gelling composition for inhibiting post-surgical adhesions |
IL95942A0 (en) * | 1989-10-13 | 1991-07-18 | Syntex Inc | Collagen-containing ophthalmic formulation |
US5256396A (en) * | 1990-01-24 | 1993-10-26 | Colgate-Palmolive Company | Topical composition |
US5252318A (en) * | 1990-06-15 | 1993-10-12 | Allergan, Inc. | Reversible gelation compositions and methods of use |
CA2044878C (en) * | 1990-08-07 | 2000-12-26 | Tacey X. Viegas | Thermally reversible and irreversible gels |
US5346703A (en) | 1990-08-07 | 1994-09-13 | Mediventures, Inc. | Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels |
GB2248842A (en) * | 1990-10-16 | 1992-04-22 | American Cyanamid Co | Film-forming polymer compositions |
US5318780A (en) * | 1991-10-30 | 1994-06-07 | Mediventures Inc. | Medical uses of in situ formed gels |
US6277410B1 (en) * | 1992-10-08 | 2001-08-21 | Supratek Pharma Inc. | Copolymer compositions for oral delivery |
JPH10500148A (ja) | 1994-03-04 | 1998-01-06 | ユニバーシティ オブ ワシントン | ブロック及びグラフトコポリマー並びにそれに関連する方法 |
US5770627A (en) * | 1995-08-16 | 1998-06-23 | University Of Washington | Hydrophobically-modified bioadhesive polyelectrolytes and methods relating thereto |
US6426415B1 (en) | 1997-09-03 | 2002-07-30 | Guilford Pharmaceuticals Inc. | Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity |
US6197785B1 (en) | 1997-09-03 | 2001-03-06 | Guilford Pharmaceuticals Inc. | Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity |
US6291425B1 (en) | 1999-09-01 | 2001-09-18 | Guilford Pharmaceuticals Inc. | Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
US6514983B1 (en) | 1997-09-03 | 2003-02-04 | Guilford Pharmaceuticals Inc. | Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage |
US6635642B1 (en) | 1997-09-03 | 2003-10-21 | Guilford Pharmaceuticals Inc. | PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same |
US6346536B1 (en) | 1997-09-03 | 2002-02-12 | Guilford Pharmaceuticals Inc. | Poly(ADP-ribose) polymerase inhibitors and method for treating neural or cardiovascular tissue damage using the same |
US6861411B1 (en) | 1997-12-02 | 2005-03-01 | Pfizer, Inc. | Method of treating eye infections with azithromycin |
US6395749B1 (en) | 1998-05-15 | 2002-05-28 | Guilford Pharmaceuticals Inc. | Carboxamide compounds, methods, and compositions for inhibiting PARP activity |
US6387902B1 (en) | 1998-12-31 | 2002-05-14 | Guilford Pharmaceuticals, Inc. | Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP |
US6239113B1 (en) | 1999-03-31 | 2001-05-29 | Insite Vision, Incorporated | Topical treatment or prevention of ocular infections |
US7056893B2 (en) | 1999-03-31 | 2006-06-06 | Insite Vision, Inc. | Topical treatment for prevention of ocular infections |
AU2001264595A1 (en) | 2000-05-19 | 2001-12-03 | Guilford Pharmaceuticals Inc. | Sulfonamide and carbamide derivatives of 6(5h)phenanthridinones and their uses |
AU2001275085A1 (en) | 2000-06-01 | 2001-12-11 | Guilford Pharmaceuticals Inc. | Methods, compounds and compositions for treating gout |
WO2016141182A1 (en) | 2015-03-03 | 2016-09-09 | Yee Richard W | Compositions and methods for treating ocular diseases |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3579465A (en) * | 1967-10-16 | 1971-05-18 | Wyandotte Chemicals Corp | Aqueous gels of polyoxyethylated polyoxypropylene glycol adducts of ethylene diamine |
CA1072413A (en) * | 1976-07-13 | 1980-02-26 | West Laboratories | Poloxamer gel systems with gelling temperatures higher than room temperature |
-
1984
- 1984-05-09 ES ES532317A patent/ES8601706A1/es not_active Expired
- 1984-05-09 CA CA000453947A patent/CA1224148A/en not_active Expired
- 1984-05-11 DK DK233884A patent/DK164481C/da active
- 1984-05-15 DE DE8484400982T patent/DE3484969D1/de not_active Expired - Fee Related
- 1984-05-15 EP EP19840400982 patent/EP0126684B1/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
ES532317A0 (es) | 1985-11-16 |
CA1224148A (en) | 1987-07-14 |
EP0126684A2 (en) | 1984-11-28 |
DK233884A (da) | 1984-11-17 |
EP0126684A3 (en) | 1986-02-05 |
DK164481B (da) | 1992-07-06 |
DK164481C (da) | 1992-11-16 |
DK233884D0 (da) | 1984-05-11 |
DE3484969D1 (de) | 1991-10-02 |
EP0126684B1 (en) | 1991-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8601706A1 (es) | Una composicion farmaceutica | |
US5091171B1 (en) | Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use | |
LV5725A4 (lv) | Gelu veidojosa oftalmologiska kompozicija | |
GB2362100B (en) | Wound gels | |
SE8901672L (sv) | System foer avgivning av en substans med biologisk eller farmakologisk verkan | |
DK124091D0 (da) | Farmaceutisk genprodukt | |
DE69212850T2 (de) | Verwendung von Karrageenan in topischen ophthalmologischen Zusammensetzungen | |
NZ218948A (en) | Pharmaceutical preparations containing viscous gels for administration by syringe | |
DE3687458T2 (de) | Filmbildende arzneimitteltraeger zur verabreichung von arzneimitteln an naegeln | |
DE69013833D1 (de) | Zusammensetzung und methode zur verhütung von verklebungen zwischen körpergewebe. | |
DE69736998D1 (de) | Nitroimidazole enthaltende gel zusammensetzung | |
MY101570A (en) | Novel pharmaceutical compositions for topical application with systemic action | |
ATE66140T1 (de) | Salbengrundlage und salbe. | |
WO2001013899A3 (de) | Wirkstoffhaltiges therapeutisches system mit mindestens zwei polymerhaltigen schichten | |
ATE54824T1 (de) | System zur arzneistoffabgabe mit erhoehter bioakzeptanz. | |
AU1612588A (en) | Pulsating transdermal drug delivery system | |
DE69812100D1 (de) | Adenosin enthaltendes arzneimittel | |
FI893681A0 (fi) | N-2,3-butadienyltri- och tetra-aminoalkanderivat. | |
PT1276477E (pt) | Medicamentos contendo acido pantotenico | |
TH9143A (th) | ส่วนประกอบของเจบทาแผลและวิธีการใช้ | |
TH9143EX (th) | ส่วนประกอบของเจบทาแผลและวิธีการใช้ | |
SU1473139A1 (ru) | Средство, повышающее общую устойчивость организма |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD1A | Patent lapsed |
Effective date: 19970303 |